Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer

Hanjong Ahn

Status: Unknown

Conditions: Prostate Cancer

Treatments: Drug: DOCETAXEL

Study type: Interventional

Funder types: Other

Identifiers

NCT01530295

2007-0326

Details and patient eligibility

About

Effect of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer.

The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and prednisone are effective in the treatment of high risk localized prostate cancer.

Full description

The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and prednisone are effective in the treatment of high risk localized prostate cancer.

Enrollment: 70 estimated patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Prostate Cancer
• PSA > 20 OR
• Clinical Stage > T2C OR
• GS > 7

Trial design

70 participants in 2 patient groups

contol

No Intervention group

Description:

control group

Treatment:

Drug: DOCETAXEL

chemotherapy

Other group

Description:

neoadjuvant chemotherapy

Treatment:

Drug: DOCETAXEL